Boussard & Gavaudan Investment Management »

Bridgebio Pharma shares owned by Boussard & Gavaudan Investment Management

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Boussard & Gavaudan Investment Management from 13F filings

Historical chart of Boussard & Gavaudan Investment Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Boussard & Gavaudan Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Boussard & Gavaudan Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $46M 26k 1778.54
2021-09-30 $3.8M 2.7k 1382.57

More positions owned by Boussard & Gavaudan Investment Management

Western Digital Corp Note 3.000%11/1
Warner Bros Discovery Com Ser A (WBD)
Advanced Energy Inds Note 2.500% 9/1
Electronic Arts (EA)
Equinox Gold Corp Note 4.750%10/1
Bridgebio Pharma Note 2.500% 3/1
Alnylam Pharmaceuticals Note 1.000% 9/1
Norfolk Southern (NSC)
Guardant Health Debt 1.250% 2/1
Seagate Hdd Cayman Note 3.500% 6/0
Chefs Whse Note 2.375%12/1
Osi Systems Note 2.250% 8/0
White Mountains Insurance Gp (WTM)
Granite Constr Note 3.250% 6/1
Snowflake Note 10/0

View all positions for Boussard & Gavaudan Investment Management

Top funds holding Bridgebio Pharma

Wolverine Asset Management
Steelhead Partners
Linden Advisors
Capstone Investment Advisors
Lazard Asset Management
Millennium Management
Graham Capital Management
683 Capital Management
Aristeia Capital
FMR
Tenor Capital Management
State Street Corporation
M&G
DeepCurrents Investment Group
BlackRock

View all funds holding Bridgebio Pharma